Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.44 |
| ▸ | CES1 | P23141 | 3/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HSD17B3 | P37058 | 5/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1598481 | 0.94 | CES1 (0.49) | CES2CES1NAAAL3MBTL1MAPT | |
| SCHEMBL1127720 | 0.94 | CES1 (0.49) | CES2CES1NAAAL3MBTL1MAPT | |
| SCHEMBL3440454 | 0.94 | CES1 (0.49) | CES2CES1NAAAL3MBTL1MAPT | |
| Bromide SCHEMBL1046807 | 0.93 | CES2 (0.47) | CES2CES1NAAAL3MBTL1MAPT | |
| SCHEMBL12556749 | 0.88 | CES1 (0.46) | CES2CES1NAAAL3MBTL1MAPT | |
| SCHEMBL107173 | 0.80 | CES1 (0.50) | CES2CES1NAAAL3MBTL1MAPT | |
| SCHEMBL106336 | 0.80 | CES1 (0.50) | CES2CES1NAAAL3MBTL1MAPT | |
| Bromide SCHEMBL8757443 | 0.79 | CES1 (0.49) | CES2CES1NAAAL3MBTL1MAPT | |
| SCHEMBL3394492 | 0.79 | CES1 (0.49) | CES2CES1NAAAL3MBTL1MAPT | |
| SCHEMBL30112595 | 0.76 | KMT2A (0.48) | CES1L3MBTL1MAPTLMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124318-A1 | POLYMERIC MATERIAL AND PREPARATION METHOD THEREOF, AND DRUG-LOADING MATERIAL | SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2026-05-07 | — | — | US | disclosed |
| WO-2025015820-A1 | MODIFIED POLYHEDRAL OLIGOMERIC SILSESQUIOXANE, SILICONE SEALANT AND PREPARATION METHOD THEREFOR, AND FLEXIBLE SEMICONDUCTOR DEVICE AND THIN-FILM ENCAPSULATION METHOD THEREFOR | 深圳市首骋新材料科技有限公司 | 2025-01-23 | — | — | WO | disclosed |
| WO-2025015818-A1 | ORGANOPOLYSILOXANE, ORGANOPOLYSILOXANE COMPOSITION AND PREPARATION METHOD THEREFOR, FLEXIBLE SEMICONDUCTOR DEVICE AND THIN FILM ENCAPSULATION METHOD THEREFOR | 深圳市首骋新材料科技有限公司 | 2025-01-23 | — | — | WO | disclosed |
| WO-2025002473-A1 | POLYMER MATERIAL AND PREPARATION METHOD THEREFOR AND DRUG-LOADING MATERIAL | 南方科技大学 | 2025-01-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124318-A1 | POLYMERIC MATERIAL AND PREPARATION METHOD THEREOF, AND DRUG-LOADING MATERIAL | FLT4, PF4, PYGL | CES2 594/4885CES1 748/4885NAAA 2065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.